RecallGuardianCanada
Drugs· Type I· Updated October 19, 2026

Dantrium Intravenous (Dantrolene sodium for injection): Presence of particulate matter

Critical priority
What you should do
  1. 1Consult your healthcare provider for any health concerns.
  2. 2Contact the recalling firm if you have any questions about the recall.
  3. 3Report any health product related side effects to Health Canada.
  4. 4Report any other health product safety complaints to Health Canada.
The issue

Contamination

Affected product

Dantrium Intravenous (Dantrolene sodium for injection)

Where it was sold

Canada (national)Reported in the official notice — confirm there.

Issued by

Health Canada — Drugs and health products

Read the official Government of Canada notice

RecallGuardian ranks, illustrates and rewrites recalls in plain language. The official notice is authoritative — confirm model numbers, lot codes, dates and remedies there.

All recalls